@_APollack

Chair and Professor of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center

Miami, FL
Joined June 2018
Alan Pollack, MD, PhD retweeted
Yes, GETUG AFU-16 and RTOG 9601 are the main complimentary randomized trials to the SPPORT trial. The GETUG trial is the most comparable, because both SPPORT and GETUG used short term ADT. All three trials showed outcome benefits from the addition of ADT to prostate bed RT.
3
1
15